MDGL
MDGL
US5588681057
Madrigal Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 958.403.000 180.133.000
432.1%
Cost of Revenue 56.148.000 6.233.000
800.8%
Gross Profit 902.255.000 173.900.000
418.8%
1.202.352.000 671.775.000
79.0%
Operating Income -300.097.000 -497.875.000
39.7%
Pretax Income -288.284.000 -465.892.000
38.1%
Net Income Common Stockholders -288.284.000 -465.892.000
38.1%
-- --
--
-- --
--
ende